Literature DB >> 33491096

Diagnostic Value and Practicability of Serration Pattern Analysis by Direct Immunofluorescence Microscopy in Pemphigoid Diseases.

Maike M Holtsche1, Nina van Beek, Axel Künstner, Hauke Busch, Detlef Zillikens, Enno Schmidt.   

Abstract

In pemphigoid diseases, direct immunofluorescence can be used to differentiate 2 patterns of antibody deposition at the dermal-epidermal junction; u- and n-serrated pattern. The u-serrated pattern is found in epidermolysis bullosa acquisita, and n-serrated pattern in all other pemphigoid diseases. To determine the detection frequency of these serrated patterns and the optimal thickness of biopsy cryosections, 2 patient cohorts obtained form our routine autoimmune laboratory were analysed; a retrospective cohort (n = 226) and a prospective cohort (n = 156). [AQ1] In 76% (291/382) of biopsies, a pattern was recog-nized, of which 96% (278/291) and 4% (13/291) had an n- or u-serrated pattern, respectively. A u-serrated pattern was seen in all epidermolysis bullosa acquisita biopsies confirmed by serology. No antibodies against type VII collagen were detected in any of the sera from biopsies with n-serrated pattern. No differences between the detection frequencies of serrated pattern were seen with respect to age, sex, biopsy site, or section thickness, while the detection frequency was higher in patients with serum anti-BP180 reactivity compared with those without. In conclusion, serrated pattern analysis using direct immunofluorescence has a high detection frequency and specificity for epidermolysis bullosa acquisita and will further facilitate the diagnosis of latter disorder.

Entities:  

Keywords:  autoantibody; direct immunofluorescence microscopy; pemphigoid disease; serration pattern analysis

Mesh:

Substances:

Year:  2021        PMID: 33491096      PMCID: PMC9366507          DOI: 10.2340/00015555-3748

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  24 in total

1.  Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.

Authors:  Joost M Meijer; Gilles F H Diercks; Enno Schmidt; Hendri H Pas; Marcel F Jonkman
Journal:  JAMA Dermatol       Date:  2016-08-01       Impact factor: 10.282

Review 2.  Review of autoimmune blistering diseases: the Pemphigoid diseases.

Authors:  B S Daniel; D F Murrell
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-07-11       Impact factor: 6.166

Review 3.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology.

Authors:  Nina van Beek; Stine Krüger; Tarek Fuhrmann; Susanne Lemcke; Stephanie Goletz; Christian Probst; Lars Komorowski; Giovanni Di Zenzo; Marian Dmochowski; Kossara Drenovska; Michael Horn; Hana Jedlickova; Cezary Kowalewski; Ljiljana Medenica; Dedee Murrell; Aikaterini Patsatsi; Shamir Geller; Soner Uzun; Snejina Vassileva; Xuejun Zhu; Kai Fechner; Detlef Zillikens; Winfried Stöcker; Enno Schmidt; Kristin Rentzsch
Journal:  J Am Acad Dermatol       Date:  2020-01-28       Impact factor: 11.527

5.  Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA).

Authors:  Vannina Seta; Françoise Aucouturier; Jonathan Bonnefoy; Christelle Le Roux-Villet; Valérie Pendaries; Marina Alexandre; Sabine Grootenboer-Mignot; Michel Heller; Nicole Lièvre; Liliane Laroche; Frédéric Caux; Matthias Titeux; Alain Hovnanian; Catherine Prost-Squarcioni
Journal:  J Am Acad Dermatol       Date:  2016-03-03       Impact factor: 11.527

6.  International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita.

Authors:  C Prost-Squarcioni; F Caux; E Schmidt; M F Jonkman; S Vassileva; S C Kim; P Iranzo; M Daneshpazhooh; J Terra; J Bauer; J Fairley; R Hall; M Hertl; J S Lehman; B Marinovic; A Patsatsi; D Zillikens; V Werth; D T Woodley; D F Murrell
Journal:  Br J Dermatol       Date:  2018-05-08       Impact factor: 9.302

7.  Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.

Authors:  M M Holtsche; S Goletz; N van Beek; D Zillikens; S Benoit; K Harman; S Walton; J English; M Sticherling; A Chapman; N J Levell; R Groves; H C Williams; I R König; E Schmidt
Journal:  Br J Dermatol       Date:  2018-07-05       Impact factor: 9.302

Review 8.  Pemphigoid diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Lancet       Date:  2012-12-11       Impact factor: 79.321

9.  The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy.

Authors:  J J A Buijsrogge; G F H Diercks; H H Pas; M F Jonkman
Journal:  Br J Dermatol       Date:  2011-06-02       Impact factor: 9.302

10.  Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.

Authors:  Nina van Beek; Kristin Rentzsch; Christian Probst; Lars Komorowski; Michael Kasperkiewicz; Kai Fechner; Inga M Bloecker; Detlef Zillikens; Winfried Stöcker; Enno Schmidt
Journal:  Orphanet J Rare Dis       Date:  2012-08-09       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.